Clinical Trials Arena July 19, 2024
Has the data see-saw tipped the other way and are sponsors collecting too much data? The Clinical Trials Arena team investigates.
As technology evolves and it becomes easier to collect data, the question is now if data collection has tipped too far.
Extra data can be incredibly helpful for sponsors – the standout example being Pfizer’s studies of Viagra as a blood pressure drug until the discovery of its potential in erectile dysfunction. But on the flip side, collecting extra blood or tests not only puts strain on patients but also the sites.
The number of data points being collected by sponsors has increased dramatically over the past decade, with research conducted by Duke-Margolis Health Policy Center showing there has...
Today's Sponsors
Today's Sponsor